US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.00

+1.303.36%

Pre-market: 40.000.00000.00%04:00 EDT

Volume:63.45K

Turnover:2.54M

Market Cap:272.00M

PE:- -

High:40.58

Open:39.41

Low:39.41

Close:38.70

52wk High:41.49

52wk Low:22.33

Shares:6.80M

Float Shares:6.80M

Volume Ratio:0.43

T/O Rate:0.93%

Dividend:0.28

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Upstream Bio presents results from VALIANT trial at ERS Congress

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

The Second Act of Biotech

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares

Cboe data shows mixed options sentiment in Moderna with shares down 3.87%

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40

MT Newswires Live

Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial

Poolbeg Pharma to spotlight POLB 001 at global scientific and investor conferences

Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

NEJM publishes Phase 1/2 clinical data on daraxonrasib

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/IDNA/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":40,"timestamp":1789675200000,"preClose":38.7,"halted":0,"volume":63447,"hourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"04:00 EDT","volume":2,"amount":80,"timestamp":1789718413277,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.033591731266149796,"floatShares":6800000,"shares":6800000,"eps":0,"marketStatus":"Pre-Mkt","change":1.3,"latestTime":"09-18 06:36:18 EDT","open":39.41,"high":40.58,"low":39.41,"amount":2543963,"amplitude":0.030233,"askPrice":46.89,"askSize":100,"bidPrice":35.84,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":40,"sharesOutstanding":5100000,"nav":38.722209,"aum":263311021.2,"dividendRate":0.007,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":40,"preClose":40,"latestTime":"04:00 EDT","volume":2,"amount":80,"timestamp":1789718413277,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":40,"preClose":40,"latestTime":"17:15 EDT","volume":203,"amount":8225.49,"timestamp":1789679712782,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4270998634880497,"impliedVol":0.275,"impliedVolPercentile":0.788},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":6800000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4270998634880497,"shares":6800000,"dividePrice":0.28,"high":40.58,"amplitude":0.030233,"preClose":38.7,"low":39.41,"week52Low":22.33,"pbRate":"--","week52High":41.49,"institutionHeld":0,"latestPrice":40,"eps":0,"divideRate":0.007,"volume":63447,"delay":0,"ttmEps":0,"open":39.41,"prevYearClose":26.19,"prevWeekClose":38.06,"prevMonthClose":39.26,"prevQuarterClose":33.75,"fiveDayClose":37.88,"twentyDayClose":40.75,"sixtyDayClose":31.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665326159","title":"Upstream Bio presents results from VALIANT trial at ERS Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326159?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:10","pubTimestamp":1788858619,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) presented results from the Phase 2 VALIANT clinical trial evaluating the safety and efficacy of verekitug in adults with severe ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-results-from-valiant-trial-at-ers-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-presents-results-from-valiant-trial-at-ers-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4139","MEDX","HYLG","IDNA","GDOC","UPB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665157325","title":"Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2665157325","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665157325?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:30","pubTimestamp":1788852600,"startTime":"0","endTime":"0","summary":"– Verekitug, 100 mg dosed every 12 weeks, reduced AAER by 56% compared to placebo in patients with severe asthma – – Verekitug also delivered clinically meaningful improvements in lung function (FEV1)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3357341/0/en/upstream-bio-presents-results-from-the-phase-2-valiant-trial-of-verekitug-for-the-treatment-of-severe-asthma-in-oral-presentation-at-ers-congress-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","TSDD","TSII","TSLQ","TLA","09766","TSLY","TSLP","CRSH","TSLR","GDOC","TSLW","TESC","TSLG","TSLI","TSL","07366","TSLT","TSLS","TSYY","TEST","NVIB","TSLZ","07766","TESL","ELOL","MEDX","TSLL","09366","TSLO","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665531933","title":"The Second Act of Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2665531933","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665531933?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:08","pubTimestamp":1788779310,"startTime":"0","endTime":"0","summary":"Pfizer sells dopamine. Moderna made the COVID vaccine. Both are betting their next decade on medicines that barely existed when their stocks peaked...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-second-act-of-biotech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","SGXZ57979304.SGD","MRNY","SG9999001176.SGD","LU0225284248.USD","BK4585","LU0225771236.USD","LU1023059063.AUD","MRNX","SG9999002232.USD","WDNA","LU1894683264.USD","SG9999002224.SGD","SG9999001176.USD","BK4568","IE00BLSP4452.SGD","LGHT","PFE","IE00BBT3K403.USD","MRNA","LU0122379950.USD","LU0321505868.SGD","BK4534","LU1066053197.SGD","BK4551","BK4007","SG9999011175.SGD","SG9999003800.SGD","LU0058720904.USD","BK4501","BK4532","BK4588","LU2596442595.SGD","BK4139","LU0306806265.USD","IE0002270589.USD","IDNA","GNOM","BK4548","BK4592","IE00B3T34201.USD","LU0170899867.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0985481810.HKD","SG9999013999.USD","BK4533","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0234572021.USD","BK4581","LU1057294990.SGD","LU1883839398.USD","BK4599","IE00B19Z3581.USD","LU0321505439.SGD","LU0868494617.USD","LU1066051498.USD","OZEM","BK4550","LU1894683348.USD","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665682593","title":"Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2665682593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665682593?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:01","pubTimestamp":1788598891,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ACRS) ), ( ($EYPT) ), ( ($VRTX) ), ( ($GTLB) ) and ( ($NB) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","BBH","SG9999001176.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD","IBB","LU2456880835.USD","BK4607","IE0002270589.USD","LU1778281490.HKD","VRTX","BK4613","LU2468319806.SGD","LU1093756325.SGD","LU0417517546.SGD","LU1093756168.USD","SG9999013999.USD","GNMX","IE00B4R5TH58.HKD","LU1069344957.HKD","LU1674673428.USD","TBXU","BK4533","IE00BFTCPJ56.SGD","GTLB","PBE","LU1559883803.SGD","LU2236285917.USD","IBBQ","IE0002141913.USD","IE00B19Z9Z06.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","EYPT","LU0079474960.USD","IDNA","IE0009355771.USD","IE00B2B36J28.USD","IE00B894F039.SGD","LU2462157665.USD","IE00B19Z9P08.USD","LU2362541513.USD","LU2089984988.USD","LU2324357040.USD","BIB","IE00B19Z3B42.SGD","LU0757428866.USD","VERX","LU0289739699.SGD","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","IBB","LABU","BK4585","MRNX","FFOX","MEDI","PINK","BBP","BK4535","FRTY","TBXU","PSCH","HELX","IDNA","BMED","XLVX","IEIH","EKG","GH","BK4551","PTH","RSPH","IYH","TECB","GNMX","SYNB","GDOC","BK4196","GNOM","LFSC","LU0109394709.USD","LU0889565916.HKD","BK4588","LU0320765992.SGD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351836","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351836?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:22","pubTimestamp":1788553320,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837300.USD","LU0061475181.USD","LU2461242641.AUD","LU2746668461.USD","IE00BJJMRX11.SGD","LU1551013425.SGD","THNR","LU1093756325.SGD","LU1974910355.USD","BK4588","LU0683600562.USD","IE00B2B36J28.USD","LU2471134796.USD","LU0823434583.USD","CANC","LU2750360997.AUD","LU1804176565.USD","LU0203201768.USD","LGHT","BK4139","MEDX","LU2471134952.CNY","BK4501","LU2896262040.SGD","SG9999017495.SGD","LU2237443465.HKD","BK4532","IE00B1BXHZ80.USD","LLY","LU2213496289.HKD","MRNX","LU2361045086.USD","LU2471134879.HKD","LU0345770993.USD","IE00BKDWB100.SGD","GB00BDT5M118.USD","IE0002141913.USD","IE00BK4W5M84.HKD","LU2271345857.HKD","MRNA","SGXZ51526630.SGD","IE00BKPKM429.USD","LU2552382215.SGD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0006306889.USD","LU2089984988.USD","IE00B775H168.HKD","LU0823416689.USD","LU2106854487.HKD","XBI","ELIL","LU0109394709.USD","LU0234572021.USD","LU0096364046.USD","LU0354030438.USD","FTXH","MEDI","LU1064131342.USD","TRUH","BK4551","IE00BJJMRY28.SGD","LU2324357040.USD","LU0320765059.SGD","LU2552382132.HKD","LU2237443549.SGD","LU1267930730.SGD","LU1127390331.HKD","LU0106261372.USD","LABU","LU0466842654.USD","IE00BJLML261.HKD","IE00BFTCPJ56.SGD","LU0882574139.USD","SGXZ99366536.SGD","LU0323591593.USD","LU1868836914.USD","LU2417539215.USD","GDOC","SG9999015952.SGD","SG9999015945.SGD","XLV","LU0471298777.SGD","SG9999018865.SGD","LU0787776722.HKD","LU2491049909.HKD","LU0689472784.USD","LU2023250330.USD","SGXZ31699556.SGD","SG9999001176.SGD","IHF","PPH","LU1061106388.HKD","LU1917777945.USD","LU2361044949.HKD","LU0256863811.USD","LU0058720904.USD","IE0009355771.USD","LU0820562030.AUD","RXL","LU1989771016.USD","LU2756315318.SGD","SG9999018857.SGD","SG9999014906.USD","LU0109391861.USD","LU2112291526.USD","LU0316494557.USD","LU2552382058.USD","LU1691799644.USD","LU1035775433.USD","LU1093756168.USD","OZEM","LU1814569148.SGD","LU2168564149.EUR","PJP","LU0823434740.USD","BK4599","SG9999015986.USD","LU0122379950.USD","IE00B7KXQ091.USD","LU0456855351.SGD","LU0943347566.SGD","TMED","IE00BJT1NW94.SGD","JDOC","BK4534","IE00BK4W5L77.USD","LU0354030511.USD","LU2237443978.SGD","LU0889565916.HKD","LU1232071149.USD","LU0158827948.USD","LLYX","LU1069344957.HKD","LU0708995401.HKD","LU2063271972.USD","LU0094547139.USD","LU1720051017.SGD","LU1720051108.HKD","HRTS","IE00BWXC8680.SGD","LU2264538146.SGD","LU0256863902.USD","LU1868837136.USD","LU0198837287.USD","LU2462157665.USD","LU2468319806.SGD","IE00BN29S564.USD","BK4548","IE0001KFT4U8.USD","IE00B4JS1V06.HKD","SG9999014898.SGD","SG9999015978.USD","LU1868836591.USD","IE0005OL40V9.USD","IBB","LU0114720955.EUR","SG9999001176.USD","BK4007","LLYZ","LU0417517546.SGD","LU2168563687.JPY","SG9999014880.SGD","LU0385154629.USD","LU1280957306.USD","LU2237443382.USD","IHE","LU2089283258.USD","IDNA","LU2357305700.SGD","FHLC","SGXZ81514606.USD","LU1623119135.USD","LU0471298694.HKD","LU1291159041.SGD","LU1988902786.USD","LU0238689110.USD","LU0097036916.USD","LU2237438978.USD","LU1629891620.HKD","IE00BJJMRZ35.SGD","LU2456880835.USD","LU2236285917.USD","LU2265009873.SGD","LU2471134523.USD","LU2746668974.SGD","IE00BFSS8Q28.SGD","LU1366192091.USD","WDNA","LU1145028129.USD","ELIS","LLII","LU0345770308.USD","BK4568","LU0225283273.USD","LU0353189763.USD","BK4516","MHIP","LU0079474960.USD","LU0353189680.USD","LU0174119429.USD","IE00BFSS7M15.SGD","LU2023250504.SGD","BK4581","LU2168564065.EUR","LU2360106947.USD","MRNY","LU0266013472.USD","LU2361044865.SGD","LU0158827781.USD","LU0210536198.USD","IE0004445239.USD","LU2491050154.USD","LU2089284900.SGD","LU2168564222.USD","IE0004445015.USD","LU0640476718.USD","LU2602419157.SGD","LU2111349929.HKD","LU1323610961.USD","BK4585","LU0320765992.SGD","LU0672654240.SGD","LU0203202063.USD","SG9999014914.USD","LU1979441026.SGD","LU2237443622.USD","LU1057294990.SGD","LU2211815571.USD","LU0964807845.USD","SG9999013999.USD","LU0133085943.USD","LU0786609619.USD","BK4533","LU1868836757.USD","AGNG","LU0432979614.USD","IE00B1XK9C88.USD","LU1712237335.SGD","LU2168564495.EUR","LU2491050071.SGD","LU2237443895.HKD","LU2087625088.SGD","LU2756315664.SGD","LU2108987350.USD","LU2028103732.USD","LU0820561909.HKD","LU2023251221.USD","LU2750360641.GBP","LU0289739699.SGD","LU0882574055.USD","LU0820561818.USD","LU1023059063.AUD","SGXZ57979304.SGD","LU1548497426.USD","GNOM","ILDR","LU2462591350.SGD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033473","title":"Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033473","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033473?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:00","pubTimestamp":1788526800,"startTime":"0","endTime":"0","summary":"EQT to Buy Insurance Broker McGill in $2 Billion DealEQT has agreed to buy a majority stake in insurance broker McGill and Partners for $2 billion, the Swedish investment group said.----Tesla-Challeng","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0187121727.USD","LU2458330243.SGD","TSLO","LU0823421416.USD","LU0274383776.USD","TESL","CHAT","IE00B3M56506.USD","LU0198837287.USD","LU2133065610.SGD","TEK","LU1935043023.USD","LU0154236417.USD","LU0323591593.USD","LU0316494557.USD","LIT","LU0289960550.SGD","LU2279689827.SGD","RXL","MRNX","LU0130517989.USD","IE000KEQY171.SGD","ADBE","LGHT","LU1035775433.USD","LU2065171402.SGD","LU1934455863.HKD","LU2242649171.HKD","BK4023","BK4612","LU1232071149.USD","LU2237443622.USD","LU0889566641.SGD","LU0882574139.USD","LU1261432733.SGD","LU0211331839.USD","LU1861558580.USD","LU0133085943.USD","BK4548","LU1066051498.USD","SGXZ51526630.SGD","LU2322448791.USD","LU0070302665.USD","IE00BFXG0V08.USD","IE00BLSP4452.SGD","LU2089284900.SGD","LU2361044949.HKD","IE00B2B36J28.USD","LU2413666426.HKD","IE0034235303.USD","LU2360032135.SGD","LU2473716301.USD","ESLG","LU1069344957.HKD","LU1814569148.SGD","LU0912757837.SGD","SNVD.UK","LU2347655073.USD","LU0683600562.USD","LU2125154935.USD","LU1778281490.HKD","LU1823568750.SGD","LU2089985449.USD","LU2756315318.SGD","BK4501","LU0985320562.USD","LU0823434740.USD","LU2237443465.HKD","SG9999014542.SGD","LU0056508442.USD","HK0000914660.USD","LU0320765489.SGD","LU2462157665.USD","SOXX","LU2097344431.USD","LU0861579265.USD","TSL","SG9999002232.USD","IE00BD6J9T35.USD","IE0034235188.USD","IE00BBT3K403.USD","LU1923623000.USD","LU1069347547.HKD","LU0980610538.SGD","LU1035773651.USD","LU1803068979.SGD","LU0265550946.USD","LU0494093205.USD","LU2491050154.USD","IE00BMPRXR70.SGD","SG9999015341.SGD","LU2028103732.USD","HK0000306701.USD","WDNA","LU0210533765.USD","LU0642271901.SGD","LU1267930490.SGD","LU0528227936.USD","LU2112291526.USD","IE00BYQQ9H92.USD","LU1202635105.USD","LU1032466523.USD","LU0061475181.USD","LU1244550577.SGD","METV","IE0004091025.USD","LU0823411888.USD","IE00B775H168.HKD","LU2100268510.USD","IDNA","LU1983299246.USD","LU2360107168.USD","BK4528","BK4585","LU2237443382.USD","LU0868494708.USD","LU1242518931.SGD","ELOL","SG9999001176.USD","FTEC","LU0203345920.USD","SG9999004303.SGD","LU0124676726.USD","LU0127658192.USD","LU0210536198.USD","LU0949170772.SGD","LU2125909247.SGD","LU2125154778.USD","USXF","BK4555","IE00BK4W5M84.HKD","LU1066051811.HKD","LU0011850046.USD","HK0000532082.HKD","LU0444971666.USD","LU0203202063.USD","LU1571399168.USD","LU1316542783.SGD","IE00BJJMRZ35.SGD","LU1642822529.SGD","LU1721428933.USD","07788","LU2286300806.USD","LU0308772762.SGD","SG9999014575.USD","LU1992135399.USD","LU2168564495.EUR","HK0000304805.HKD","LU0158827781.USD","LU0208291251.USD","LU2860962120.EUR","LU1629891620.HKD","SGXZ99366536.SGD","TSLP","LU0234570918.USD","LU1720051108.HKD","LU1861220033.SGD","IE00BN29S564.USD","HK0000819398.USD","LU0965509101.SGD","SGXZ80539844.SGD","LU0672654240.SGD","NVDL","09366","LU0511384066.AUD","LU2896262040.SGD","EFIV","NVDD","LU0708994859.HKD","LU2463028550.USD","BK4587","IE00B1XK9C88.USD","IE00BJTD4V19.USD","LU2237957811.SGD","IE00BWXC8680.SGD","BK4605","HK0000306685.HKD","ANV","LU1861127337.USD","IE00BQXX3D17.EUR","TTEQ","LU2237438978.USD","LU1861559042.SGD","LU2403377893.USD","LU1934455194.USD","LU0070217475.USD","LU2602419157.SGD","LU2087625088.SGD","LU1023059063.AUD","LU0432979614.USD","TESC","STSLAmain","LU2242650005.HKD","LU0347712357.USD","LU2265009873.SGD","LU1061106388.HKD","LU0661504455.SGD","LU1144417596.USD","TSLT","IE0002141913.USD","LU1046421795.USD","IXN","IE00B7KXQ091.USD","LU0345774391.USD","LU0965509010.AUD","AGOX","LFGY","LU2237443549.SGD","HRTS","LU2095319765.USD","LU0266013472.USD","LU0289739343.SGD","ROM","TEST","LU2491049909.HKD","LU1880398554.USD","ADBU","LU1037948897.HKD","LU2552382058.USD","LU1988902786.USD","IXJ","LU2210149790.SGD","LU0820561909.HKD","LU1992135472.HKD","IDRV","IE000Q6AESB8.SGD","BK4579","BK4559","IE0001KFT4U8.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","SG9999014880.SGD","LU0097036916.USD","DIPS","LU0689626769.HKD","LU1057294990.SGD","NULC","LU0109391861.USD","LU2244417387.USD","LU2168564065.EUR","LU2394011477.USD","LU1923622291.USD","IE00BMPRXQ63.HKD","LU2168563687.JPY","LU1066053197.SGD","LU1868836914.USD","IE00BMPRXN33.USD","IE00B19Z9505.USD","ESUM","LU2111349929.HKD","LU0082616367.USD","IE000YTNTUN2.SGD","LU0979878070.USD","LU0795875169.SGD","LU1585245621.USD","LU2092937148.SGD","LU0708995401.HKD","LU2272731865.HKD","WANT","LU1400636491.USD","LU0225283273.USD","LU2381873111.SGD","LU0353189763.USD","LU0820561818.USD","LU2083900584.USD","LU1718418525.SGD","IE000ITXATA3.USD","LU2272731600.USD","LU2264538146.SGD","BK4567","PAWZ","GNOM","LU1929549753.HKD","LU2552382215.SGD","LU1815336760.USD","LU1323610961.USD","LU2023250330.USD","JGRO","IE0004445015.USD","XLV","FDRV","LU2106854487.HKD","IE00BJTD4N35.SGD","BK4554","IHE","TSLL","LU1923622614.USD","LU2430703095.HKD","LU2237443895.HKD","THMR","LU2077746001.SGD","LU0823414551.USD","LU0557290698.USD","LU0345774631.USD","IE00BDRTCR15.USD","LU0323239441.USD","LU0957791311.USD","LU0238689110.USD","LU1400636574.HKD","LU2047632596.USD","LU2210150020.SGD","IE00B5TLWC47.USD","IE00BKDWB100.SGD","LU0077335932.USD","LU1366333091.USD","LU1244550221.USD","LU2272731782.SGD","NVC","LU0094547139.USD","LU2746668461.USD","NVDY","CNEQ","LU1093756168.USD","LU1732799900.SGD","IE0004086264.USD","LU1989772923.USD","LU0323240290.USD","LU0289961442.SGD","LU0553294199.USD","LU2092627202.USD","SG9999015978.USD","LU0234572021.USD","LU0345770308.USD","LU2237957902.USD","SG9999015945.SGD","BK4527","LU0210528500.USD","SGXZ81514606.USD","LU0444973449.USD","IE0034235295.USD","LU2637965513.SGD","NVD","GB00BDT5M118.USD","LU2087621335.USD","LU1989772840.SGD","LU1623119135.USD","SG9999000418.SGD","LU2468319806.SGD","LU0058720904.USD","LU0738911758.USD","LU1267930813.SGD","SOXQ","TSDD","CLSE","VGT","CHPX","IE00BQXX3C00.GBP","LU2430703251.USD","IE00BK4W5L77.USD","PPH","NVDG","LU2065169927.USD","CMAG","LU1804176565.USD","LU2294711713.HKD","LU0792757196.USD","LU2168564222.USD","LU0689472784.USD","LU0726765562.USD","LU0823416689.USD","LU0048584097.USD","BK4592","LU1435385759.SGD","BK4614","09788","AIPI","LU1935043536.SGD","LU0256863902.USD","LU2505996509.AUD","TSLA","LU0138981039.USD","LU1162221912.USD","LU0175139822.USD","LU0889565833.HKD","LU1852331112.SGD","LU0203201768.USD","LU2108987350.USD","LU0390134368.USD","LU0640476718.USD","LU2148611432.USD","IE00BZ1G4Q59.USD","LU0053666078.USD","IE00BFTCPJ56.SGD","LU1861215975.USD","LU0096364046.USD","BK4099","IE00B775SV38.USD","LU2361044865.SGD","LU0109392836.USD","TSLW","IE00BKPKM429.USD","WATS","BK4007","LU0170899867.USD","LU2089984988.USD","LU1941712348.USD","SG9999015952.SGD","BK4566","LU2471134523.USD","LU1791710400.SGD","LU1400636657.SGD","IE00B4YYXB79.USD","SG9999014906.USD","LU2360106780.USD","LU0868494617.USD","LU2420271590.USD","LU0314104364.USD","LU0057025933.USD","LU1917777945.USD","BK4503","LU1084165304.USD","07366","WISE","LU0310800379.SGD","LU2324357040.USD","09388","LU2249611893.SGD","MRK","LU1291159041.SGD","LU0545039389.USD","LU2023250843.SGD","LU1839511570.USD","LU2357305700.SGD","LU1003077747.HKD","ADBG","LU2089283258.USD","LU0942090050.USD","LU2999663052.SGD","NVDU","LU1496350502.SGD","LU2413666699.HKD","BK4551","LU0965509283.SGD","LU1934455277.USD","SGXZ57979304.SGD","BK4604","MRNY","ILDR","SG9999017495.SGD","BK4574","LU2271345857.HKD","LU2417539215.USD","HK0000320223.HKD","LU1267930573.SGD","LU2746668974.SGD","LU2357125470.USD","LU0823434583.USD","LU2430703178.SGD","SG9999015358.SGD","SG9999018857.SGD","LU0128525929.USD","SNVDAmain","LU1066051225.USD","LU0477156953.USD","TSLZ","LU1951198990.SGD","ARTY","NVDS","LU2191332357.HKD","LU0143551892.USD","LU0466842654.USD","BK4608","LU1153585028.USD","TRFK","IE00B19Z8W00.USD","LU0211327993.USD","LU0158827948.USD","LU0320765059.SGD","LU1868836757.USD","NVDB","NVDS.UK","LU2054465674.USD","BK4529","LU1989771016.USD","LU1093756325.SGD","NVD2.UK","LU1127390331.HKD","NVDX","SHOC","LU2756315664.SGD","IE0004445239.USD","LU1720051017.SGD","SGXZ31699556.SGD","TYLG","HK0000304797.USD","LU0348723411.USD","LU2213496289.HKD","NVDA","TSLQ","BK4543","LU0719512351.SGD","LU1670756490.USD","LU2471134796.USD","LU0081259029.USD","IE00BQXX3F31.USD","LU2487616109.SGD","TSLY","LU0276348264.USD","LU1989764748.USD","LU1645745479.HKD","LU2168564149.EUR","IE00BFSS7M15.SGD","LU0174119429.USD","BK4581","LU1699723380.USD","SG9999014559.SGD","HK0000320264.USD","LU0345768153.USD","LU0211328371.USD","LU0345768740.USD","LU2452424414.USD","LU2462591277.SGD","BK4549","BK4139","SG9999001424.SGD","LU0215105999.USD","TSYY","LU0069063385.USD","LU0310799852.SGD","LU0823421333.USD","LU2326559502.SGD","BK4511","LU1868836591.USD","IE00B1BXHZ80.USD","LU1935042488.USD","LU2505996681.GBP","09766","FHLC","LU1366192091.USD","LU1633808545.USD","LU1941712264.USD","LU1116320737.USD","IE00BJJMRX11.SGD","TSII","IE0009355771.USD","LU2237443978.SGD","LU0080751232.USD","BK4550","SPTE","BK4533","LU2462591350.SGD","SG9999001440.SGD","LU2236285917.USD","SG9999013999.USD","LU1935042991.SGD","LU1242518857.USD","LU2491050071.SGD","HK0000914686.HKD","LU0029864427.USD","LU1037948541.HKD","LU2097344357.USD","LU2125909916.SGD","LU0079474960.USD","TSLR","LU0345769128.USD","IE00B19Z8X17.USD","TLA","LU0395794307.EUR","LU1674673691.USD","IE00BN8TJ469.HKD","07388","LU2458330169.SGD","IE0003U64NQ7.SGD","IE0009356076.USD","VHT","LU0354030438.USD","SG9999015986.USD","LU0823414478.USD","LU1119994496.HKD","LU1548497426.USD","LU2592432038.USD","LU0107464264.USD","TTXU","NVDO","BK4532","LU0788109477.HKD","IE00BDCRKT87.USD","IE00B4JS1V06.HKD","LU2023250504.SGD","LU1064131342.USD","NVII","IE00BYXW3230.USD","LU1267930730.SGD","LU1791710582.SGD","LU2065171311.SGD","LU2931357623.SGD","LU2317271919.USD","LU1712237335.SGD","LU0256863811.USD","AIFD","LU1235294995.USD","SG9999014898.SGD","IE00BHPRN162.USD","LU1880398471.USD","IE00BJT1NW94.SGD","LU1983260115.SGD","LU2211815571.USD","LU2543165471.USD","3NVD.UK","IE00B3S45H60.SGD","LU2750360997.AUD","USD","LU1496350171.SGD","LU2471134879.HKD","07766","2NVD.UK","IE00B3SWFQ91.USD","LU1821325948.USD","LU2954938101.SGD","TSLI","TRUH","SMH","JDOC","LU2750360641.GBP","LU2065170008.USD","LU1551013425.SGD","LU0096362180.USD","LU2433249047.HKD","LU0859254822.USD","IETC","NVYY","LU0342679015.USD","LU1429558221.USD","BK4568","FTXH","LU0417517546.SGD","SOXY","LU1674673428.USD","LU0106261372.USD","LU0203347892.USD","LU1145028129.USD","LU1201861249.SGD","IE00BLSP4239.USD","LU0345770993.USD","LU1974910355.USD","LU1244550494.USD","NVIW.SI","SG9999002224.SGD","IYH","LU1691799644.USD","LU0006306889.USD","XLK","LU0472753341.HKD","LU2461242641.AUD","LU2125909759.SGD","LU0957808578.USD","BMED","LU0122379950.USD","LU0354030511.USD","LU2023251221.USD","VT","LU1430594728.SGD","LU2290526834.HKD","BK4141","LU1116320901.HKD","SMOG","LU0098860793.USD","LU0820562030.AUD","LU0724617625.USD","LU2063271972.USD","LU0157215616.USD","LU1280957306.USD","LU2361045086.USD","LU1935042215.USD","ABFL","FDTX","IE000W1ABFV2.USD","LU0787776722.HKD","LU2357627491.SGD","SG9999014567.USD","SMHX","SNPE","LU0964807845.USD","LU0353189680.USD","LU0795875086.SGD","LU2125909593.SGD","LU1951200564.SGD","LU0130102774.USD","TSLG","GDOC","LU2322448957.HKD","LU0061474705.USD","LU1868837136.USD","IE0009G5SDU7.USD","LU0265550359.USD","BK4588","LU0648001328.SGD","SGXZ23171101.USD","LU0786609619.USD","LU2552382132.HKD","IE00BFSS8Q28.SGD","LU1914381329.SGD","LU0061474960.USD","LU3102509885.SGD","LU1732800096.USD","LU1868837300.USD","NVD3.UK","SG9999014914.USD","LU0345769631.USD","LU0251132253.USD","IE0005OL40V9.USD","BK4516","BK4534","LU0072462426.USD","LU0476273544.USD","TSLS","LU2247934214.USD","IE00BSNM7G36.USD","LU1551013342.USD","LU2250418816.HKD","SG9999018865.SGD","IE00BZ199S13.USD","LU0267386448.USD","IE00B5949003.HKD","LU0965508806.USD","LU1989764664.SGD","NVDQ","IE000M9KFDE8.USD","LU2506951792.HKD","SG9999001176.SGD","CRSH","FAI","LU2456880835.USD","LU2471134952.CNY","LU0320765646.SGD","MRNA","LU0943347566.SGD","IE00BJLML261.HKD","NVDW","BK4598","GAMR","LU1815333072.USD","LU1979441026.SGD","IE00BJJMRY28.SGD","LU2347655156.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804589","title":"Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804589","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804589?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:57","pubTimestamp":1788469031,"startTime":"0","endTime":"0","summary":"Moderna Chief Legal Officer Shannon Thyme Klinger disposes of USD 485,271.45 in common sharesModerna Chief Legal Officer Klinger Shannon Thyme reported net sales of 4,519 common shares on Sep. 1, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2vgysz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Moderna Chief Legal Officer Shannon Thyme Klinger Disposes of USD 485,271.45 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BK4532","BK4533","BK4551","BK4568","MRNY","BK4585","BK4534","MRNX","BK4548","GNOM","BK4588","BK4501","IDNA","WDNA","LGHT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664809840","title":"Cboe data shows mixed options sentiment in Moderna with shares down 3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809840?lang=en_us&edition=fundamental","pubTime":"2026-09-04 02:50","pubTimestamp":1788461417,"startTime":"0","endTime":"0","summary":"Cboe data shows mixed options sentiment in Moderna (MRNA), with shares down $5.83 near $144.98. Options volume relatively light with 76k contracts ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-3-87-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cboe-data-shows-mixed-options-sentiment-in-moderna-with-shares-down-3-87-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GNOM","BK4534","MRNY","BK4551","LGHT","BK4533","BK4585","MRNA","MRNX","BK4568","BK4501","BK4532","BK4588","BK4139","WDNA","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880504","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880504?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:39","pubTimestamp":1788457140,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","IE00B7KXQ091.USD","IHE","LU1023059063.AUD","IE0001KFT4U8.USD","LU2357305700.SGD","BK4534","LU2552382132.HKD","SGXZ31699556.SGD","LU0289739699.SGD","LU0471298777.SGD","XBI","LU2552382058.USD","LU0353189763.USD","LU2106854487.HKD","SG9999015986.USD","LU2168564222.USD","LU2750360641.GBP","MEDI","SG9999018857.SGD","LU0882574055.USD","LU2746668974.SGD","SG9999015952.SGD","LU1691799644.USD","LU2023250330.USD","IBB","LU1548497426.USD","LU2063271972.USD","LU2211815571.USD","LU2462157665.USD","LU2462591350.SGD","LU0238689110.USD","LU1057294990.SGD","BK4548","IE00BJLML261.HKD","LABU","LU1623119135.USD","LU1629891620.HKD","LU2023250504.SGD","LU0006306889.USD","IE00BKPKM429.USD","LU0096364046.USD","LU2237443382.USD","LU1064131342.USD","LU2456880835.USD","LU2471134879.HKD","LU0354030511.USD","LU1917777945.USD","LU0823434740.USD","LU0320765992.SGD","LU0345770308.USD","LU2237443549.SGD","LU2237443622.USD","LU2461242641.AUD","SG9999014898.SGD","IE00BKDWB100.SGD","LU2237443978.SGD","MHIP","SGXZ81514606.USD","PJP","LU0943347566.SGD","LU0882574139.USD","LU0097036916.USD","LU1280957306.USD","BK4588","LU1291159041.SGD","LU2168564149.EUR","LU2746668461.USD","BK4516","LU0820561909.HKD","LU1551013342.USD","LU2265009873.SGD","JDOC","IE00B4JS1V06.HKD","IE00B4R5TH58.HKD","LU2324357040.USD","SG9999001176.SGD","BK4139","LU0174119429.USD","LU1868836757.USD","IE0009355771.USD","IE00BFSS7M15.SGD","LU1868836591.USD","LU0106261372.USD","LU0122379950.USD","LU2750360997.AUD","SG9999014906.USD","BK4551","BK4585","BK4568","LU2471134796.USD","LU0109394709.USD","LU0823416689.USD","LU2471134523.USD","LU2028103732.USD","LU2168564495.EUR","LU2552382215.SGD","LU1712237335.SGD","LU2168563687.JPY","LU0432979614.USD","TMED","LU1989771016.USD","IE00B1BXHZ80.USD","IE0005OL40V9.USD","LU1983299246.USD","RXL","IE0004445015.USD","THNR","LU1093756325.SGD","LU0689472784.USD","LU1720051108.HKD","LU2237438978.USD","SG9999013999.USD","LU0114720955.EUR","LU1974910355.USD","LU2896262040.SGD","LU2112291526.USD","LU0079474960.USD","LU2089984988.USD","LU1232071149.USD","LU2237443895.HKD","WDNA","LU0354030438.USD","AGNG","LU0820562030.AUD","LU0889565916.HKD","LU2087625088.SGD","LU0417517546.SGD","TRUH","LU0133085943.USD","LU0823434583.USD","IE00BK4W5L77.USD","LU2108987350.USD","LU1366192091.USD","MRNX","SG9999015978.USD","LLYX","SG9999014914.USD","LU2361044949.HKD","ELIL","LU2237443465.HKD","MRNA","LU1868837300.USD","LU1069344957.HKD","LU1720051017.SGD","LU0353189680.USD","BK4501","LU0683600562.USD","IE00B775H168.HKD","LU2471134952.CNY","IDNA","LU1979441026.SGD","MEDX","LU1035775433.USD","SG9999001176.USD","PPH","LU0094547139.USD","IE00BFSS8Q28.SGD","LU1804176565.USD","LU1868837136.USD","BK4007","LLII","LU0256863811.USD","LU0786609619.USD","LU2360106947.USD","LU0058720904.USD","LU2491050071.SGD","LLYZ","BK4599","IE00BJJMRX11.SGD","LU0820561818.USD","LU1093756168.USD","LU1868836914.USD","SG9999017495.SGD","OZEM","IE00BWXC8680.SGD","LU0225283273.USD","IE00BN29S564.USD","LU2602419157.SGD","BK4581","LU0471298694.HKD","LU1551013425.SGD","LU0466842654.USD","LU2417539215.USD","LU0256863902.USD","LU0708995401.HKD","IE0002141913.USD","LGHT","LU2491050154.USD","LU1145028129.USD","LU0640476718.USD","LU1061106388.HKD","LU2491049909.HKD","LU2023251221.USD","LU2756315318.SGD","CANC","LU0109391861.USD","HRTS","SGXZ57979304.SGD","LU2468319806.SGD","LU2089284900.SGD","LU1323610961.USD","GDOC","LU2756315664.SGD","LU1267930730.SGD","LU0266013472.USD","BK4532","SGXZ51526630.SGD","LU0061475181.USD","LU2111349929.HKD","GNOM","BK4533","LU0158827781.USD","LU2264538146.SGD","IE00BJJMRY28.SGD","LU0203202063.USD","LU2271345857.HKD","SG9999015945.SGD","SG9999018865.SGD","LU2236285917.USD","LU2361045086.USD","LU2361044865.SGD","IE00BJT1NW94.SGD","LU1814569148.SGD","LU0456855351.SGD","LU2168564065.EUR","LU1127390331.HKD","LLY","IE00BFTCPJ56.SGD","LU0345770993.USD","GB00BDT5M118.USD","XLV","IE00BK4W5M84.HKD","LU0234572021.USD","FTXH","LU0210536198.USD","LU2213496289.HKD","SGXZ99366536.SGD","IE00B1XK9C88.USD","LU0158827948.USD","ELIS","FHLC","LU0323591593.USD","LU0320765059.SGD","LU0672654240.SGD","LU0787776722.HKD","LU2089283258.USD","LU0385154629.USD","IE0004445239.USD","LU0964807845.USD","SG9999014880.SGD","MRNY","LU0198837287.USD","ILDR","LU0316494557.USD","IE00B2B36J28.USD","LU1988902786.USD","LU0203201768.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803700","title":"Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803700?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:04","pubTimestamp":1788451496,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. plans to launch a targeted ground gravity survey at its wholly owned ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU1674673691.USD","LU0823416689.USD","BK4532","IBB","LU0417517546.SGD","LU1069344957.HKD","BBH","LU0234570918.USD","PBE","IE00B19Z9Z06.USD","IBBQ","BIB","LU0109394709.USD","LU2362541273.HKD","LU0058720904.USD","IE00B2B36J28.USD","LU2362541513.USD","BK4139","IDNA","TBXU","IE00BFTCPJ56.SGD","LU2237438978.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","VRTX","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0889565916.HKD","SG9999013999.USD","LU1093756168.USD","LU0320765992.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0079474960.USD","LU1430594728.SGD","BK4585","LU2324357040.USD","SGXZ57979304.SGD","IE00B19Z9P08.USD","IE0002141913.USD","GNMX","LU0061475181.USD","LU1035775433.USD","IE00B19Z3581.USD","LU2236285917.USD","SG9999001176.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664219808","title":"Why Moderna Stock's Cancer Vaccine Rally Sparked a Rare Sell Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2664219808","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664219808?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:10","pubTimestamp":1788448200,"startTime":"0","endTime":"0","summary":"Moderna has received its second Sell rating on Wall Street, but the downgrade has little to do with the drugmaker's commercial potential or pipeline prospects.Rothschild & Co. Redburn analyst Simon Ba","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4501","IDNA","GNOM","LGHT","BK4568","BK4585","MRNX","MRNA","BK4533","BK4532","MRNY","BK4588","BK4551","BK4139","BK4548","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","TEVA","LU2324357040.USD","LU1983299246.USD","IE0009355771.USD","LU0320765992.SGD","PTH","BK4584","BK4557","XBI","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4007","BK4559","LU0128526141.USD","BK4566","IE00BJJMRZ35.SGD","BK4596","IDNA","BK4588","IE0002141913.USD","LU0889565916.HKD","BBH","IE00BJT1NW94.SGD","BK4137","BK4581","HCSG","BK4139","BK4585","LABU","RVMD","CANC","IE0009354923.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878125","title":"Rothschild & Co Redburn Downgrades Moderna to Sell From Neutral, Adjusts PT to $81 From $40","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878125","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878125?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:21","pubTimestamp":1788427316,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $108, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","IDNA","BK4532","BK4551","MRNX","BK4548","BK4588","GNOM","MRNA","WDNA","BK4139","BK4501","LGHT","MRNY","BK4568","BK4533","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664982743","title":"Transgene Jumps 20% on Positive Cancer Vaccine Data in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664982743","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664982743?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:20","pubTimestamp":1788423613,"startTime":"0","endTime":"0","summary":"Transgene jumps 20% on positive cancer vaccine data in early trialSept 3 (Reuters)-TransgeneTRNG.PAshares surged 20% in early Paris trading on Thursday, after the French biotechnology company reported","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL6N44V0L4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4551","GNOM","IDNA","BK4532","MRNY","MRNA","BK4534","BK4501","BK4548","BK4585","BK4568","BK4139","LGHT","BK4588","MRNX","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664682193","title":"Poolbeg Pharma to spotlight POLB 001 at global scientific and investor conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664682193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664682193?lang=en_us&edition=fundamental","pubTime":"2026-09-03 14:09","pubTimestamp":1788415748,"startTime":"0","endTime":"0","summary":"Poolbeg Pharma Ltd. ( ($GB:POLB) ) has issued an update. Poolbeg Pharma will showcase its lead cancer immunotherapy-support asset POLB 001 and broa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/poolbeg-pharma-to-spotlight-polb-001-at-global-scientific-and-investor-conferences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/poolbeg-pharma-to-spotlight-polb-001-at-global-scientific-and-investor-conferences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664828323","title":"Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2664828323","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664828323?lang=en_us&edition=fundamental","pubTime":"2026-09-03 09:25","pubTimestamp":1788398717,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines yesterday and set a price target of $315.00. Charles Zhu has gi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-daraxonrasib-strength-rasolve-301-upsizing-and-unchanged-315-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-daraxonrasib-strength-rasolve-301-upsizing-and-unchanged-315-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","CANC","BBH","IDNA","IE00BJJMRZ35.SGD","LU0109394709.USD","LU0320765992.SGD","RVMD","LU0889565916.HKD","BK4139","IE0009354923.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664422868","title":"Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664422868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664422868?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:44","pubTimestamp":1788392661,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has shared an update. Vertex Minerals Ltd, an Australian minerals and resources company listed on the ASX as VTX...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","IE00B19Z9Z06.USD","LU1430594728.SGD","MTX","IE0002141913.USD","LU0289739699.SGD","LU0757428866.USD","LU0079474960.USD","BBH","LU0823416689.USD","LU2236285917.USD","LU0061475181.USD","IBBQ","LU0889565916.HKD","LU2362540622.SGD","TBXU","LU2362541273.HKD","LU1674673691.USD","LU2362541513.USD","LU2324357040.USD","SG9999001176.SGD","LU0256863811.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","PBE","IE00B19Z3B42.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4532","BK4585","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","SG9999001176.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0109394709.USD","LU1559883803.SGD","GNMX","BK4023","LU0320765992.SGD","VRTX","IE0009355771.USD","BIB","LU0058720904.USD","LU2417539215.USD","LU1585245621.USD","IDNA","LU0432979614.USD","SG9999013999.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844659","title":"NEJM publishes Phase 1/2 clinical data on daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844659?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:55","pubTimestamp":1788386116,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) “announced that The New England Journal of Medicine has published a report describing data from the Phase 1/2 clinical ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nejm-publishes-phase-1-2-clinical-data-on-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nejm-publishes-phase-1-2-clinical-data-on-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","BK4139","CANC","IE0002141913.USD","IE00BJJMRZ35.SGD","IDNA","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","RVMD","PTH","LU0320765992.SGD","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","BBH","IE0009354923.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844613","title":"New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844613","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844613?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:50","pubTimestamp":1788385800,"startTime":"0","endTime":"0","summary":"Results support the clinical rationale for RASolve 301, an ongoing Phase 3 trial in RAS mutant metastatic non-small cell lung cancer REDWOOD CITY, Calif., Sept.  02, 2026 (GLOBE NEWSWIRE) --  Revoluti","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355564/0/en/new-england-journal-of-medicine-publishes-phase-1-2-clinical-data-on-revolution-medicines-rasonque-daraxonrasib-in-metastatic-non-small-cell-lung-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU2360107325.USD","BK4605","IE0009354923.USD","LU2298322129.HKD","IE00BJT1NW94.SGD","LU2487616109.SGD","LU1548497426.USD","PTH","RVMD","BK4588","LU1861220033.SGD","IE00BD6J9T35.USD","LU1978683503.SGD","IE00B4R5TH58.HKD","LU0124384867.USD","IE00BZ199S13.USD","NVIB","IE00B2B36J28.USD","L","BK4512","GDOC","BK4141","LU0109394709.USD","LU1983260115.SGD","IE0002141913.USD","LU1720051017.SGD","BK4107","ONX","BK4585","IE00BFTCPJ56.SGD","ON","CANC","LU1861219969.SGD","IE0009355771.USD","ONG","LU0053666078.USD","LU0348723411.USD","BBH","LU0889565916.HKD","IE00BFMHRM44.USD","LU2357305700.SGD","LU0320765992.SGD","IDNA","LU0724618433.USD","LU1854104046.USD","LU1854103824.USD","BK4139","LU1861215975.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}